CEO Mark Dybul takes $300K base salary cut; Francois Binette named COO

Lunai Bioworks Inc.

CEO Dybul base salary reduced from $850K to $550K/year effective Jan 1, 2023; variable comp cap raised to $800K/year.
Dybul awarded $100K cash bonus for 2022 performance, payable by March 15, 2023.
Francois Binette appointed COO effective Nov 1, 2022; base salary increased to $420K/year plus 40,000 stock options.
CFO Luisa Puche base salary increased to $350K/year; granted 80,000 stock options for 2022.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Francois Binette

Chief Operating Officer

LNAI · Lunai Bioworks Inc.

Effective: 2022-11-01
Filed: December 16, 2022, 6:59 PM ET

On October 18, 2022, the Company appointed Francois Binette PhD, age 59, as Chief Operating Officer of the Company, effective November 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Francois Binette was appointed as Chief Operating Officer at Lunai Bioworks Inc..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

On October 18, 2022, the Company appointed Francois Binette PhD, age 59, as Chief Operating Officer of the Company, effective November 1, 2022.

View on SEC.gov

Lunai Bioworks Inc. filing history →

Source: SEC EDGAR

accession 0001731122-22-002139

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.